Pharmaceutical Company Accepts Special Inspection on Pharmacovigilance
Release time:
2020-08-17
Pharmaceutical Company Accepts Special Pharmacovigilance Inspection
News 7# On the morning of May 9 , relevant leaders of Zhejiang Adverse Drug Reaction Monitoring Center went to Jianfeng Pharmaceutical Company to carry out pharmacovigilance research exchange and special inspection. The
inspection team conducted a detailed inspection of the personnel, institutions, individual adverse reactions and group adverse events of the pharmaceutical company, and fully affirmed the pharmacovigilance work of the pharmaceutical company. At the same time, it is hoped that the pharmaceutical company can creatively carry out the pharmacovigilance work on the basis of checking and filling the vacancy. The relevant person in charge ofPharmaceutical Company said that he would continue to implement the main responsibility of the holder, do a good job in the management of the whole life cycle of drugs, and effectively ensure that the people use "
rest assured medicine " .
78 , the pharmaceutical company sent personnel to attend the 2020 Jinhua pharmacovigilance and risk warning seminar. during the meeting, drug marketing license holders made speeches on the difficulties and doubts in their respective work, and Lu Xiaoqin, chief of the monitoring department of Zhejiang provincial center, gave one-on-one doubts and guidance. (Fan Fangwei)
Related Links:What is Pharmacovigilance?
Pharmacovigilance is scientific research and activities related to the detection, evaluation, understanding and prevention of adverse reactions or any other problems that may be related to drugs. Pharmacovigilance involves not only adverse drug reactions, but also other drug-related problems, such as substandard drugs, drug treatment errors, lack of effectiveness reports, medication for indications that are not recognized without sufficient scientific basis, case reports of acute and chronic poisoning, evaluation of drug-related mortality, drug abuse and misuse, adverse interactions between drugs and chemical drugs, other drugs and food.
Pharmacovigilance starts from the safety of the user to discover, evaluate and prevent adverse drug reactions. Require doubts to report, regardless of the quality of drugs, usage, dosage is normal or not, more attention to comprehensive analysis method to explore the causal relationship, easy to be accepted by the majority of reporters. The main contents of pharmacovigilance include: early detection of adverse reactions of unknown drugs and their interactions; discovery of the growth trend of adverse reactions of known drugs; analysis of risk factors and possible mechanisms of adverse drug reactions; quantitative analysis of risk/
benefit evaluation, release of relevant information, promotion of drug supervision and management and guidance of clinical drug use.
The purpose of pharmacovigilance includes: evaluating the benefits, harms, effectiveness and risks of drugs to promote their safe, reasonable and effective application; preventing safety issues related to medication, improving patient safety in medication, treatment and auxiliary medical care; Educating and informing patients about drug-related safety issues, and improving public health and safety related to medication.The ultimate goal of pharmacovigilance is the rational and safe use of drugs; risk/
benefit evaluation and communication of marketed drugs; training, education, and timely feedback of relevant information to patients.
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page